SEC Form 4 · accession 0001193125-26-330505

Apnimed, Inc. · APMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Executive Officer · Director

Period of report

Jul 30, 2026

Accepted (ET)

Aug 3, 2026 · 4:01 pm EDT

Rule 10b5-1 plan

box not checked

Issuer CIK

0001745648

Table I — non-derivative securities

No Table I lines on this filing.

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$9.50	Aug 3, 2026	D	74,128	D	—	Mar 6, 2035	Class A Common Stock	74,128	0	D
Stock Option (Right to Buy)^F2	$9.50	Aug 3, 2026	A	74,128	A	—	Mar 6, 2035	Common Stock	74,128	74,128	D
Stock Option (Right to Buy)^F3	$8.15	Aug 3, 2026	D	1,186,278	D	—	Jun 23, 2036	Class A Common Stock	1,186,278	0	D
Stock Option (Right to Buy)^F3	$8.15	Aug 3, 2026	A	1,186,278	A	—	Jun 23, 2036	Common Stock	1,186,278	1,186,278	D
Stock Option (Right to Buy)^F3	$16.00	Jul 30, 2026	A	108,916	A	—	Jul 29, 2036	Class A Common Stock	108,916	108,916	D
Stock Option (Right to Buy)^F3	$16.00	Aug 3, 2026	D	108,916	D	—	Jul 29, 2036	Class A Common Stock	108,916	0	D
Stock Option (Right to Buy)^F3	$16.00	Aug 3, 2026	A	108,916	A	—	Jul 29, 2036	Common Stock	108,916	108,916	D

F1Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock.
F225% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after March 6, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
F325% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after June 1, 2026 and the remainder of the shares vest and become exercisable in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.